Financhill
Buy
53

CME Quote, Financials, Valuation and Earnings

Last price:
$276.27
Seasonality move :
4.85%
Day range:
$274.99 - $277.00
52-week range:
$224.62 - $290.79
Dividend yield:
1.81%
P/E ratio:
26.79x
P/S ratio:
15.56x
P/B ratio:
3.54x
Volume:
580K
Avg. volume:
2M
1-year change:
15.41%
Market cap:
$99.7B
Revenue:
$6.1B
EPS (TTM):
$10.32

Earnings Data

Next earnings date for CME
Feb 04
2026
Most recent earnings per share
$2.49
Missed by $0.14
(Oct 22/2025)
Consensus Estimate
$2.63
(Oct 22/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CME Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/04/2026 Q4 $1.6B -- -- $2.72 --
10/22/2025 Q3 $1.5B $1.5B $2.49 $2.63 -$0.14
07/23/2025 Q2 $1.7B $1.7B $2.81 $2.94 -$0.13
04/23/2025 Q1 $1.7B $1.6B $2.62 $2.81 -$0.19
02/12/2025 Q4 $1.5B $1.5B $2.40 $2.45 -$0.05
10/23/2024 Q3 $1.6B $1.6B $2.50 $2.65 -$0.15
07/24/2024 Q2 $1.5B $1.5B $2.42 $2.53 -$0.11
04/24/2024 Q1 $1.5B $1.5B $2.35 $2.45 -$0.10
02/14/2024 Q4 $1.4B $1.4B $2.24 $2.28 -$0.05
10/25/2023 Q3 $1.3B $1.3B $2.06 $2.22 -$0.16
07/26/2023 Q2 -- $1.4B $2.14 -- --
04/26/2023 Q1 -- $1.4B $2.43 -- --
02/08/2023 Q4 -- $1.2B $1.75 -- --
10/26/2022 Q3 -- $1.2B $1.87 -- --
07/27/2022 Q2 -- $1.2B $1.82 -- --
04/28/2022 Q1 -- $1.3B $1.95 -- --
02/09/2022 Q4 -- $1.1B $1.71 -- --
10/27/2021 Q3 -- $1.1B $2.58 -- --
07/28/2021 Q2 -- $1.2B $1.42 -- --
04/28/2021 Q1 -- $1.3B $1.60 -- --
02/10/2021 Q4 -- $1.1B $1.18 -- --
10/28/2020 Q3 -- $1.1B $1.15 -- --
07/29/2020 Q2 -- $1.2B $1.40 -- --
04/29/2020 Q1 -- $1.5B $2.14 -- --
02/12/2020 Q4 -- $1.1B $1.31 -- --
10/30/2019 Q3 -- $1.3B $1.78 -- --
07/31/2019 Q2 -- $1.3B $1.43 -- --
05/01/2019 Q1 -- $1.2B $1.39 -- --
02/14/2019 Q4 -- $1.2B $1.09 -- --
10/25/2018 Q3 -- $904.2M $1.21 -- --
07/26/2018 Q2 -- $1.1B $1.66 -- --
04/26/2018 Q1 -- $1.1B $1.76 -- --
02/01/2018 Q4 -- $900M $8.63 -- --
10/26/2017 Q3 -- $890.8M $0.91 -- --
08/01/2017 Q2 -- $924.6M $1.22 -- --
04/27/2017 Q1 -- $1B $1.18 -- --
02/02/2017 Q4 -- $899.9M $1.10 -- --
10/27/2016 Q3 -- $854.4M $1.39 -- --
07/28/2016 Q2 -- $906.4M $0.95 -- --
04/28/2016 Q1 -- $934.2M $1.09 -- --
02/05/2016 Q4 -- $813.8M $0.86 -- --

CME Group, Inc. Earnings Questions

  • How Much did CME Group, Inc. Generate in Revenue Last Quarter?

    CME Group, Inc. reported $1.5B worth of top line sales in its most recent quarter.

  • Did CME Group, Inc. Beat Earnings Last Quarter?

    CME Group, Inc. announced earnings per share of $2.49 which represents a miss of analyst forecast a $2.63 per share.

  • Is CME Group, Inc. Profitable?

    CME Group, Inc. reported $1.3B that represents $3.51 per share over the last quarter.

  • What is the Analyst Consensus for CME Group, Inc. EPS Next Year?

    CME Group, Inc.'s earnings are forecast to grow from $9.67 per share to $10.19 per share next year representing an increase of 15.45%.

  • When is CME Group, Inc.'s Earnings Date?

    CME Group, Inc.'s next earnings date is February 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock